Justice Department Announces $3.8 Billion In False Claims Act Recoveries In FY 2013


On December 20, 2013, the Justice Department announced a total of $3.8 billion dollars in settlements and judgments from civil cases involving the False Claims Act for Fiscal Year (FY) 2013. Total recoveries under the False Claims Act since January 2009 have reached $17 billion.

The largest recoveries in FY 2013 related to health care fraud, which totaled $2.6 billion. Of this amount, $1.8 billion was from alleged false claims for drugs and medical devices under federally insured health programs. Many of these settlements involved allegations that pharmaceutical manufactures promoted their drugs improperly for uses not approved by the Food and Drug Administration.

Recoveries in qui tam cases during FY 2013 totaled $2.9 billion, with whistleblowers recovering $345 million. The number of qui tam suits filed in FY 2013 increased to 752. The Federal Government also announced an additional $443 million in recoveries for state Medicaid programs.

To read the Justice Department press release, click here.

Reporter, Lauren E. Slive, Atlanta, + 1 404 572 3592, lslive@kslaw.com

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© King & Spalding | Attorney Advertising

Written by:


King & Spalding on:

Readers' Choice 2017
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:

Sign up to create your digest using LinkedIn*

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.

Already signed up? Log in here

*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.